We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Vuzix® Corporation (NASDAQ: VUZI), (“Vuzix” or, the “Company”), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced an upcoming online panel discussion
Medical technology company Hologic has agreed to acquire Finnish-French molecular diagnostic solutions and instrumentation developer Mobidiag for an enterprise value of around $795m. The deal consists of a
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Ibex Medical Analytics, a pioneer in artificial intelligence (AI) based cancer diagnostics, today announced a
Teva Canada, a subsidiary of Teva Pharmaceutical Industries, has introduced a new autoinjector for Ajovy (fremanezumab) subcutaneous injection. Ajovy is a preventive treatment for migraines in adults who
Healthcare company Abbott has secured CE mark approval for its next-generation TriClip transcatheter tricuspid valve repair system. TriClip is claimed to be the first-of-its-kind minimally invasive tricuspid heart
emids, which has built its reputation as one of healthcare’s most trusted partners for health information technology (HIT) engineering and development, is going strategically upstream with this latest
UK-based next-generation point of care (POC) diagnostics testing company LumiraDx has announced a merger with special purpose acquisition company CA Healthcare Acquisition (CAHC) in a deal worth $5bn.
Astrotech Corporation’s (NASDAQ: ASTC) subsidiary, BreathTech Corporation announced today that it has signed an Investigator-Initiated Study Agreement with the Cleveland Clinic Foundation (Cleveland Clinic). Under this agreement, BreathTech’s
Chemence Medical, a world leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion® skin closure
Bausch + Lomb has secured approval from the US Food and Drug Administration (FDA) for its ClearVisc dispersive ophthalmic viscosurgical device (OVD) for use in ophthalmic surgery. ClearVisc